Literature DB >> 27423266

Uncovering the Role of the Methylome in Dementia and Neurodegeneration.

Hans-Ulrich Klein1, Philip L De Jager2.   

Abstract

Our understanding of the epigenome has advanced dramatically over the past decade, particularly in terms of DNA methylation, a modification found throughout the genome. Studies of the brain and neurons have outlined an increasingly complex architecture involving not just CG dinucleotide methylation but also methylation of other dinucleotides, and modifications of methylated bases such as 5-hydroxymethylcytosine. Different modifications may play an important role in brain development, function and decline; recent descriptions of the effects of aging and neurodegenerative processes such as Alzheimer disease on methylation profiles have ushered in an era of DNA methylome-wide association studies. Rapidly improving technologies and study designs are returning robust results, and investigations of the human brain's epigenome are increasingly feasible, complementing insights gained from genetic studies.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27423266     DOI: 10.1016/j.molmed.2016.06.008

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  12 in total

1.  Bayesian integrative analysis of epigenomic and transcriptomic data identifies Alzheimer's disease candidate genes and networks.

Authors:  Hans-Ulrich Klein; Martin Schäfer; David A Bennett; Holger Schwender; Philip L De Jager
Journal:  PLoS Comput Biol       Date:  2020-04-07       Impact factor: 4.475

Review 2.  Epigenetic alterations in rheumatoid arthritis fibroblast-like synoviocytes.

Authors:  Karen M Doody; Nunzio Bottini; Gary S Firestein
Journal:  Epigenomics       Date:  2017-03-21       Impact factor: 4.778

Review 3.  The epigenome in Alzheimer's disease: current state and approaches for a new path to gene discovery and understanding disease mechanism.

Authors:  Hans-Ulrich Klein; David A Bennett; Philip L De Jager
Journal:  Acta Neuropathol       Date:  2016-08-29       Impact factor: 17.088

Review 4.  CRISPR-Mediated Epigenome Editing.

Authors:  Paul Enríquez
Journal:  Yale J Biol Med       Date:  2016-12-23

Review 5.  Klotho and the Treatment of Human Malignancies.

Authors:  Aishani Sachdeva; Jerome Gouge; Christos Kontovounisios; Stella Nikolaou; Alan Ashworth; Kenneth Lim; Irene Chong
Journal:  Cancers (Basel)       Date:  2020-06-23       Impact factor: 6.639

Review 6.  DNA methylation and de-methylation using hybrid site-targeting proteins.

Authors:  Yong Lei; Yung-Hsin Huang; Margaret A Goodell
Journal:  Genome Biol       Date:  2018-11-06       Impact factor: 13.583

7.  Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice.

Authors:  Claudia Figueroa-Romero; Kai Guo; Benjamin J Murdock; Ximena Paez-Colasante; Christine M Bassis; Kristen A Mikhail; Kristen D Raue; Matthew C Evans; Ghislaine F Taubman; Andrew J McDermott; Phillipe D O'Brien; Masha G Savelieff; Junguk Hur; Eva L Feldman
Journal:  Dis Model Mech       Date:  2019-11-15       Impact factor: 5.758

8.  Gene Body Methylation of the Lymphocyte-Specific Gene CARD11 Results in Its Overexpression and Regulates Cancer mTOR Signaling.

Authors:  Michael H McGuire; Santosh K Dasari; Hui Yao; Yunfei Wen; Lingegowda S Mangala; Emine Bayraktar; Wencai Ma; Cristina Ivan; Einav Shoshan; Sherry Y Wu; Eric Jonasch; Menashe Bar-Eli; Jing Wang; Keith A Baggerly; Anil K Sood
Journal:  Mol Cancer Res       Date:  2021-08-04       Impact factor: 5.852

9.  Genome‑wide DNA methylation profiling in a rat model with vascular dementia.

Authors:  Jong-Min Park; Yoon Ju Kim; Min Kyung Song; Jae-Min Lee; Youn-Jung Kim
Journal:  Mol Med Rep       Date:  2018-05-08       Impact factor: 2.952

Review 10.  Aging and Alzheimer's disease: Comparison and associations from molecular to system level.

Authors:  Xian Xia; Quanlong Jiang; Joseph McDermott; Jing-Dong J Han
Journal:  Aging Cell       Date:  2018-07-02       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.